TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.

Daniel V T Catenacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.